Navigation Links
Endo Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009
Date:7/1/2009

CHADDS FORD, Pa., July 1 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) will announce its second quarter financial results on July 30, 2009 and will host a conference call and webcast at 9:00 a.m. ET that day to discuss these results.

David P. Holveck, president and chief executive officer, Nancy J. Wysenski, chief operating officer, Alan Levin, chief financial officer, Ivan Gergel, M.D., executive vice president of research and development and Blaine Davis, vice president, corporate affairs will host the call.

Investors and other interested parties may call 800-901-5248 (domestic) or 617-786-4512 (international) and enter passcode 39225165. Please dial in 10 minutes prior to the scheduled start time.

A replay of the call will be available from July 30 at 1:30 p.m. ET until 12:00 a.m. ET on August 7 by dialing 888-286-8010 (domestic) or 617-801-6888 (international) and enter passcode 74683162.

A simultaneous webcast of the call may be accessed by visiting www.endo.com. In addition, a replay of the webcast will be available until 12:00 a.m. ET on August 7. The replay can be accessed by clicking on "Events" in the Investor Relations section of the website.

About Endo

Endo Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain, overactive bladder, prostate cancer and the early onset of puberty in children, or central precocious puberty (CPP). Its products include LIDODERM(R), a topical patch to relieve the pain of postherpetic neuralgia; PERCOCET(R) and PERCODAN(R) tablets for the relief of moderate-to-moderately severe pain; FROVA(R) tablets for
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial
2. Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211, a Novel Product Candidate for the Treatment of Respiratory Diseases
3. Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
4. Lotus Pharmaceuticals, Inc. Again Awarded GSP Certification
5. Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Greece by SpePharm
6. Biostar Pharmaceuticals, Inc. Begins Construction of Raw Material Processing Facility of the Herbal Plantation Base
7. Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
8. The Crohns & Colitis Foundation and Procter & Gamble Pharmaceuticals Announce 2009 Celebrating UC Success Contest Winners
9. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Vascular Imaging Applications of Its PS-Targeting Platform
10. DiaGenic to Provide MCI Biomarkers for Merz Pharmaceuticals
11. Atlantic Pharmaceuticals, Inc. Announces Completion of Successful Pre-IND Meeting with FDA for Abuse Deterrent Narcotic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... The VitalSleep anti snoring device is a mandibular advancement splint ... snorers airway to quiet snoring. , Dawn M. of Utah ... her husband by allowing them to share the same bedroom again. ... about 15 years ago and I remember nights when it was ... had to head downstairs for any relief. As the years have ...
(Date:7/31/2014)... York, New York (PRWEB) July 31, 2014 ... against Ethicon, Inc. continue to move forward in the ... District of West Virginia, Bernstein Liebhard LLP reports. According ... been scheduled to consider certain defense motions now pending ... before the U.S. Magistrate Judge on Tuesday, August 5th ...
(Date:7/31/2014)... of heroin use has been rising steadily in the ... on Drug Use and Health, the number of individuals ... (373,000) and 2012 (669,000). Emerging evidence suggests the increase ... transition from oral and/or intranasal PO use to heroin ... use, and ultimately, heroin injection. This drug-use trajectory ...
(Date:7/31/2014)... Live To Be Sober , a no-cost 24/7 confidential ... program information to people who want to help a ... addiction, proudly announced today that it has entered into ... boy, gone good. , "NBC's The Voice touched on ... new single Stomp (#Stomp; available on iTunes ) ...
(Date:7/31/2014)... Ticket Down is a reliable source ... Goods Park in suburban Denver on Tuesday, September 9th. ... has found a second home competing on American soil. They ... international friendly games and will look to have another successful ... in Commerce City, Colorado. The match will be Mexico’s second ...
Breaking Medicine News(10 mins):Health News:New Snoring Mouthpiece Reviews from VitalSleep 2Health News:Ethicon Transvaginal Mesh Lawsuits Move Forward, With Scheduling of Hearing in Federal Litigation, Bernstein Liebhard LLP Reports 2Health News:Ethicon Transvaginal Mesh Lawsuits Move Forward, With Scheduling of Hearing in Federal Litigation, Bernstein Liebhard LLP Reports 3Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 2Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 3Health News:Addiction Referral Service Live To Be Sober (LiveToBeSober.com) Announces Sponsorship of Jared Blake: Country Music’s Bad Boy, Gone Good 2Health News:Addiction Referral Service Live To Be Sober (LiveToBeSober.com) Announces Sponsorship of Jared Blake: Country Music’s Bad Boy, Gone Good 3Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO Now Available at Ticket Down 2Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO Now Available at Ticket Down 3
... abstracts underscoring the importance of testing for BRCA1/2 mutations ... week,s Society of Gynecologic Oncologists 39th Annual Meeting on ... M. D. Anderson Cancer Center. , In ... M.D. Anderson found advanced- stage ovarian cancer patients with ...
... 10 Give an Hour, (http://www.giveanhour.org ), a ... returning Veterans and their loved ones,announces that there ... In an effort to supplement the mental ... military health care system, Give an Hour,s,services are ...
... Medco Health,Solutions, Inc. (NYSE: MHS ) is scheduled ... On Monday, March 17, 2008, Timothy C. Wentworth, president ... specialty pharmacy,subsidiary, is scheduled to address the 28th Annual ... Boston Marriott Copley,Place will begin at 1:45 p.m. ET., ...
... for environmental, biological diseases if same physician is used ... for by the same doctor during their first six months ... doctors to receive proper screening for lead poisoning, anemia and ... study looked at 1,564 infants covered by Medicare. All the ...
... CITY, March 10 ZARS Pharma, Inc. ... Galderma Pharma S.A. the,exclusive promotion and distribution ... and Canada for Pliaglis(TM) (lidocaine and tetracaine) ... and safe local,anesthesia in patients undergoing potentially ...
... in California participated, MANHATTAN BEACH, Calif., March 10 ... by 2011 and the majority of,California,s population by 2040. ... the highest rate among all ethnic groups., "In ... discussing,with regard to the Latino community is immigration, there ...
Cached Medicine News:Health News:Advanced-stage ovarian cancer patients with BRCA live longer, may respond better to treatment 2Health News:1,000 Mental Health Professionals Join National Network to Provide Free Counseling to Returning Veterans and their Families 2Health News:Medco to Present at Cowen and Company and Lehman Brothers Health Care Conferences 2Health News:Continuous Doctor Care Key to Childhood Screenings 2Health News:ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic 2Health News:ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic 3Health News:New Survey Shows Solutions to Improve Latinos' Access to Health Care in California 2
(Date:7/31/2014)... YORK , July 31, 2014 ... discovering and developing better, faster and affordable treatments, ... as Senior Vice President, External Affairs. Mr. Brock ... as Head of Major Donor Relations for WWF ... In his role, Mr. Brock will guide the ...
(Date:7/31/2014)... SPRINGFIELD, Ill. , July 31, 2014 /PRNewswire/ ... (LRS) announced a new extension to its PageCenterX ... software is designed to provide downtime ... unplanned system outages. LRS is releasing the product ... the healthcare environment, EMR applications experience outages for ...
(Date:7/31/2014)... Deutschland, 31. Juli 2014  invendo medical ... („robotischen") Koloskopie-Systems für den Einmalgebrauch, verkündete heute, ... weltweit anerkannter Manager im Bereich Medizintechnik, als ... stößt. Logo - ... hochangesehener globaler Visionär der Medizintechnikbranche. Er war ...
Breaking Medicine Technology:TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2LRS Announces Downtime Reporting Solution for Healthcare 2invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 2invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 3
... Palatin Technologies,Inc. (AMEX: PTN ) announced today ... trial of PL-3994, a long acting analog of ... decompensated congestive,heart failure (CHF). The trial is being ... to the U.S. Food and Drug,Administration. Future plans ...
... Third Quarter 2007 Earnings release, you are,invited to listen to ... on Tuesday, November 6, 2007 at 9:30 a.m. EST, with ... Chief,Financial Officer. What: QIAGEN N.V. ... Tuesday, November 6, 2007 at 9:30 a.m. EST, ...
Cached Medicine Technology:Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure 2Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure 3QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Third Quarter 2007 Earnings Conference Call on the Web 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: